Mexico Hormones And Analogues HS2937 Export Data 2025 August Overview
Mexico Hormones And Analogues (HS 2937) 2025 August Export: Key Takeaways
Mexico's Hormones And Analogues (HS Code 2937) exports in August 2025 reveal a high-value pharmaceutical product, with Switzerland dominating as the top market—accounting for 47.52% of export value but only 16.93% of weight, signaling premium pricing. The U.S. follows as a key destination, reinforcing the product's specialized nature. Buyer concentration is high, with Switzerland and the U.S. driving most demand, while smaller markets like Guatemala and Nicaragua show limited but diversified trade. This analysis, covering August 2025, is based on cleanly processed Customs data from the yTrade database.
Mexico Hormones And Analogues (HS 2937) 2025 August Export Background
Mexico's Hormones And Analogues exports (HS Code 2937), covering hormones, prostaglandins, and their structural derivatives, are vital for pharmaceuticals and biotechnology, driving steady global demand. While Mexico's 2025 export policies, including the June-introduced automatic notice requirement, primarily target other goods, HS 2937 remains unaffected [HK Law]. The country's strategic role in August 2025 hinges on its established production capabilities and proximity to key markets, reinforcing its position in this specialized trade flow.
Mexico Hormones And Analogues (HS 2937) 2025 August Export: Trend Summary
Key Observations
In August 2025, Mexico's export of Hormones and Analogues under HS Code 2937 recorded a unit price of $159.61/kg, marking a continued decline from previous months and the lowest point in the year, while volume and value saw modest increases month-over-month.
Price and Volume Dynamics
The unit price for Mexico Hormones And Analogues HS Code 2937 Export has trended downward sharply since its April 2025 peak of $1,458.47/kg, with August's price down 5.7% from July's $169.33/kg. This decline aligns with typical pharmaceutical or chemical industry cycles where increased production or inventory drawdowns often lead to price softening. Volume rose 41.5% month-over-month to 42.54K kg, suggesting robust demand or competitive pricing strategies, though the overall 2025 trend shows high volatility, possibly due to seasonal stock adjustments or supply chain efficiencies.
External Context and Outlook
Mexico's 2025 trade policy updates, including the mandatory automatic export notice [HK Law], did not directly impact HS Code 2937, as it was exempted from new requirements. However, broader foreign trade rule changes, such as altered VAT exemptions and import procedures (HK Law), may have contributed to stabilized export flows. Looking ahead, the Mexico Hormones And Analogues HS Code 2937 Export market in 2025 August likely reflects adaptive responses to global demand shifts and regulatory clarity, with prices expected to remain pressured by industry oversupply dynamics.
Mexico Hormones And Analogues (HS 2937) 2025 August Export: HS Code Breakdown
Product Specialization and Concentration
The Mexico Hormones And Analogues HS Code 2937 Export market in August 2025 is heavily specialized, dominated by the sub-code for oestrogens and progestogens, which holds a 36.5 percent value share and a unit price of 407 dollars per kilogram. This high unit price disparity confirms its role as a high-value finished product. Two extreme price anomalies are present: one sub-code with a unit price of just 14 dollars per kilogram and another at 0.28 dollars per kilogram, both isolated from the main analysis due to their low value impact.
Value-Chain Structure and Grade Analysis
The non-anomalous sub-codes fall into three high-value categories: oestrogens and progestogens, corticosteroidal derivatives, and other steroidal hormones, all with unit prices ranging from 407 to 1,104 dollars per kilogram. This structure indicates trade in differentiated manufactured goods, not fungible bulk commodities, as the consistent high prices reflect advanced processing and specific medical or pharmaceutical applications.
Strategic Implication and Pricing Power
For market players, the high unit prices across categories suggest strong pricing power and a strategic focus on producing and exporting premium, finished hormone products. [Baker McKenzie] notes no new export controls for this code, supporting stable trade conditions and reinforcing the opportunity to leverage Mexico's export capabilities in high-value Hormones And Analogues throughout 2025.
Check Detailed HS 2937 Breakdown
Mexico Hormones And Analogues (HS 2937) 2025 August Export: Market Concentration
Geographic Concentration and Dominant Role
In August 2025, Mexico's export of Hormones And Analogues under HS Code 2937 shows strong geographic concentration, with Switzerland as the dominant partner, accounting for 47.52% of the export value but only 16.93% of the weight. This disparity, where value ratio significantly exceeds weight ratio, points to a high unit price per kilogram, indicating that the product is specialized and high-value, typical of manufactured pharmaceuticals rather than commodities. The United States follows as a key market, with similar high-value characteristics.
Partner Countries Clusters and Underlying Causes
The partner countries form three clear clusters based on trade patterns. First, high-value destinations like Switzerland, the United States, and Czechia likely represent major markets for finished pharmaceutical products, driven by strong healthcare demand and advanced manufacturing ties. Second, mid-tier partners such as Canada may handle intermediate goods or niche applications, given moderate value but lower weight shares. Third, low-value countries like Guatemala, Nicaragua, and Belize could involve smaller-scale trades or regional distribution, possibly due to limited infrastructure or different regulatory environments.
Forward Strategy and Supply Chain Implications
For market players, the high-value focus on markets like Switzerland and the United States suggests prioritizing supply chain efficiency and quality assurance to maintain premium pricing. Since the Mexico Hormones And Analogues HS Code 2937 Export in 2025 August faces no new export automatic notice requirements [HK Law], exporters can leverage this regulatory stability to expand into these clusters without added hurdles, while diversifying into emerging markets cautiously to balance risk.
| Country | Value | Quantity | Frequency | Weight |
|---|---|---|---|---|
| SWITZERLAND | 3.23M | 2.44K | 11.00 | 7.20K |
| UNITED STATES | 2.31M | 2.28K | 10.00 | 11.16K |
| CZECHIA | 690.93K | 22.46 | 5.00 | 1.09K |
| CANADA | 498.02K | 485.00 | 1.00 | 755.20 |
| SPAIN | 54.68K | 6.18 | 1.00 | 15.30 |
| GUATEMALA | ****** | ****** | ****** | ****** |
Get Complete Partner Countries Profile
Mexico Hormones And Analogues (HS 2937) 2025 August Export: Buyer Cluster
Buyer Market Concentration and Dominance
The buyer market for Mexico Hormones And Analogues Export in 2025 August is sharply concentrated, with one of the four segments of buyers dominating 95% of the total value under HS Code 2937. This dominant group consists of high-value, high-frequency buyers, indicating a market driven by large, regular transactions. The median market behavior is characterized by substantial value per shipment and consistent ordering patterns, reflecting a stable export environment for this manufactured product.
Strategic Buyer Clusters and Trade Role
The other buyer clusters play distinct roles. High-value, low-frequency buyers account for nearly 5% of value, likely representing occasional bulk purchases from specialized pharmaceutical or chemical firms. Low-value, high-frequency buyers contribute minimal value but high order volume, suggesting regular small-scale buyers such as distributors or local retailers. Low-value, low-frequency buyers are negligible, possibly one-off or experimental clients with insignificant impact.
Sales Strategy and Vulnerability
For exporters in Mexico, the strategic focus should prioritize maintaining relationships with the dominant high-value, high-frequency buyers to secure revenue. The low regulatory risk is an opportunity, as HS Code 2937 is not subject to new export automatic notice requirements [HK Law], simplifying compliance. The sales model should emphasize direct, contract-based engagements with key buyers, while monitoring the smaller clusters for potential growth or diversification.
| Buyer Company | Value | Quantity | Frequency | Weight |
|---|---|---|---|---|
| SICOR DE MEXICO, SA DE CV | 3.23M | 2.44K | 11.00 | 7.20K |
| INDUSTRIAS QUIMICAS FALCON DE MEXICO SA DE CV | 162.45K | 148.36 | 1.00 | 181.40 |
| PRODUCTOS CIENTIFICOS SA DE CV | 6.10K | 32.22 | 4.00 | 427.44 |
| RAUL MENDEZ MORA | ****** | ****** | ****** | ****** |
Check Full Hormones And Analogues Buyer lists
Mexico Hormones And Analogues (HS 2937) 2025 August Export: Action Plan for Hormones And Analogues Market Expansion
Strategic Supply Chain Overview
The Mexico Hormones And Analogues Export 2025 August under HS Code 2937 is defined by high-value, specialized manufacturing. Price drivers include product specification, advanced processing, and tier-1 contract volumes with key buyers. Supply chain implications center on Mexico's role as an assembly hub for premium pharmaceutical goods, requiring strict quality control and direct logistics to high-value markets like Switzerland and the United States.
Action Plan: Data-Driven Steps for Hormones And Analogues Market Execution
- Use buyer frequency data to prioritize high-value, high-frequency clients. This secures stable revenue through contract renewals and volume commitments.
- Monitor shipment weight-to-value ratios by destination. Adjust pricing and logistics to maximize returns from premium markets like Switzerland and the United States.
- Analyze sub-code unit price disparities. Focus production on high-margin categories like oestrogens and progestogens to leverage pricing power.
- Track regulatory updates for HS Code 2937. Maintain compliance simplicity and avoid disruptions, as no new export controls are expected in 2025.
Keywords
Mexico Hormones And Analogues Export 2025 August, HS Code 2937.
Take Action Now —— Explore Mexico Hormones And Analogues Export Data
Frequently Asked Questions
Q1. What is driving the recent changes in Mexico Hormones And Analogues Export 2025 August?
The unit price dropped to $159.61/kg, the lowest in 2025, due to increased volume (up 41.5% month-over-month) and industry oversupply, while regulatory stability supported steady export flows.
Q2. Who are the main partner countries in this Mexico Hormones And Analogues Export 2025 August?
Switzerland dominates with 47.52% of export value, followed by the United States and Czechia, reflecting demand for high-value pharmaceutical products.
Q3. Why does the unit price differ across Mexico Hormones And Analogues Export 2025 August partner countries?
Prices vary by product grade: oestrogens/progestogens (avg. $407/kg) and corticosteroidal derivatives (up to $1,104/kg) command premium prices, while anomalies like $0.28/kg sub-codes are outliers.
Q4. What should exporters in Mexico focus on in the current Hormones And Analogues export market?
Prioritize contracts with high-value, high-frequency buyers (95% of market value) and ensure supply chain efficiency for Switzerland and the U.S., while cautiously exploring mid-tier markets like Canada.
Q5. What does this Mexico Hormones And Analogues export pattern mean for buyers in partner countries?
Buyers in Switzerland and the U.S. benefit from stable, high-quality supply, while smaller markets may face limited access due to Mexico’s focus on premium destinations.
Q6. How is Hormones And Analogues typically used in this trade flow?
These are specialized manufactured goods, primarily for pharmaceutical applications like hormone therapies or steroidal treatments, not bulk commodities.
Q7. What is yTrade?
yTrade is a global trade data platform that provides SaaS and API access to provide accurate, structured, and searchable import-export trade data for international business decisions. It enables users to access verified shipment records, analyse buyer and supplier activity, review company trade overviews, assess compliance risks, and monitor real market demand — all from a single, scalable system.
Q8. How can yTrade benefit my business?
yTrade helps businesses:
- Identify active and verified buyers through global import data
- Discover reliable suppliers with real shipment history
- Monitor competitor previous trade activity
- Reduce sourcing and compliance risk with worldwide export data
- Support data-driven sales, procurement, and market expansion decisions
- Save time by replacing manual research with structured trade data analysis
Q9. What features does yTrade offer?
yTrade provides practical, trade-focused tools including:
- Global shipment search by HS code, product, company name, port, or country
- Detailed company trade profiles with ownership and relationship mapping
- Buyer and supplier discovery with real transaction trade records
- Basic compliance with background checks and sanctions risk screening
- Competitor's shipment tracking and selling/buying behaviour analysis
- Trade Trends to identify market demand and trade flow monitoring
- Big-Data Search engine with percised filters to generate accurate data reports
- Global Trade Data API access for Internal Softwares like CRM, ERP, and SaaS integration All data is structured, verified, and cleaned to ensure consistency and reliability.
Mexico Hormones And Analogues HS2937 Export Data 2025 April Overview
Mexico's Hormones And Analogues (HS Code 2937) Export in April 2025 shows Germany dominates with 83% share at $2,628/kg, per yTrade data. Diversify to Italy, India, UK to reduce risk.
Mexico Hormones And Analogues HS2937 Export Data 2025 February Overview
Mexico's Hormones And Analogues (HS Code 2937) export in February 2025 shows Switzerland as top buyer (22.66%) with premium prices in Brazil/India (1,370-3,338 USD/kg), per yTrade data.
